Canada markets closed

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.17+1.26 (+9.06%)
At close: 04:00PM EDT
15.17 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 320.94M
Enterprise Value 9.28M
Trailing P/E 436.70
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.33
Price/Book (mrq)1.67
Enterprise Value/Revenue 0.13
Enterprise Value/EBITDA -0.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 3-59.48%
S&P500 52-Week Change 322.38%
52 Week High 336.04
52 Week Low 38.08
50-Day Moving Average 314.79
200-Day Moving Average 312.74

Share Statistics

Avg Vol (3 month) 3227.07k
Avg Vol (10 day) 3120.22k
Shares Outstanding 521.16M
Implied Shares Outstanding 621.16M
Float 813.34M
% Held by Insiders 16.10%
% Held by Institutions 1100.03%
Shares Short (Apr 15, 2024) 42.74M
Short Ratio (Apr 15, 2024) 411.01
Short % of Float (Apr 15, 2024) 413.80%
Short % of Shares Outstanding (Apr 15, 2024) 412.97%
Shares Short (prior month Mar 15, 2024) 42.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -187.77%
Operating Margin (ttm)-193.78%

Management Effectiveness

Return on Assets (ttm)-22.89%
Return on Equity (ttm)-56.11%

Income Statement

Revenue (ttm)73.62M
Revenue Per Share (ttm)3.50
Quarterly Revenue Growth (yoy)-23.70%
Gross Profit (ttm)N/A
EBITDA -139.58M
Net Income Avi to Common (ttm)-138.24M
Diluted EPS (ttm)-6.57
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)337.15M
Total Cash Per Share (mrq)15.94
Total Debt (mrq)215.04M
Total Debt/Equity (mrq)112.07%
Current Ratio (mrq)6.25
Book Value Per Share (mrq)9.07

Cash Flow Statement

Operating Cash Flow (ttm)-92.5M
Levered Free Cash Flow (ttm)-51.68M